FDA 483 - Cardiac Insight - February 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Cardiac Insight, Inc. in Bellevue, WA, received a Form 483 citing two observations related to its quality system for the Class II Cardea SOLO device. The firm failed to adequately document corrective and preventive action (CAPA) activities and results, and its procedures for receiving, reviewing, and evaluating complaints were not adequately established, leading to untimely processing. These issues indicate a need for improved adherence to established quality system regulations.
- Office
- Seattle District Office
- Person
ID · 19ed19b2-9102-41dd-8352-1b02873246b3